Lifestyle Intervention With Smartphone App and isCGM for People at High Risk of Type 2 Diabetes: Randomized Trial

被引:7
|
作者
Kitazawa, Masaru [1 ]
Takeda, Yasunaga [1 ]
Hatta, Mariko [1 ]
Horikawa, Chika [2 ]
Sato, Takaaki [1 ]
Osawa, Taeko [1 ]
Ishizawa, Masahiro [1 ]
Suzuki, Hiroshi [1 ]
Matsubayashi, Yasuhiro [1 ]
Fujihara, Kazuya [1 ]
Yamada, Takaho [1 ]
Sone, Hirohito [1 ,3 ]
机构
[1] Niigata Univ, Dept Hematol Endocrinol & Metab, Fac Med, Niigata 9518510, Japan
[2] Univ Niigata Prefecture, Fac Human Life Studies, Dept Hlth & Nutr, Niigata 9500806, Japan
[3] Niigata Univ, Dept Internal Med, Fac Med, 1-754 Asahimachi, Niigata 9518510, Japan
关键词
continuous blood glucose monitor; prevention; prospective randomized trial; smartphone; educational intervention; DOSE-RESPONSE METAANALYSIS; HEALTH MANAGEMENT CENTER; PHYSICAL-ACTIVITY; GLUCOSE-LEVELS; JAPANESE; INDIVIDUALS; PREVENTION; HBA1C;
D O I
10.1210/clinem/dgad639
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims: Although conventional interventions for people at high risk of developing type 2 diabetes are usually conducted face-to-face, such interventions are burdensome for health care providers. We developed a lifestyle intervention program combining lifestyle coaching via a smartphone application augmented by intermittently scanned continuous glucose monitoring without burdening health care providers. Its effectiveness for glycemic control and body weight reduction in people at risk of type 2 diabetes was investigated.Materials and Methods: For this 12-week randomized unblinded trial with offline recruitment, participants with a hemoglobin A1c level of 5.6% to 6.4% or a fasting blood glucose of 110 to 125 mg/dL and body mass index (BMI) >23 kg/m2 but <40 kg/m(2) were randomly assigned to the intervention group (App) and control group (C). The primary endpoint was the difference in time in range of blood glucose between 70 and 140 mg/dL (3.9-7.8 mmol/L) before and after the study period between the 2 groups.Results: Among 168 patients (mean age, 48.1 years; mean BMI, 26.6 kg/m(2); and male, 80.4%), 82 and 86 were assigned to the App group and C group, respectively. After 12 weeks, time in range of blood glucose at 70 to 140 mg/dL significantly improved in the App group compared with the C group (-2.6 minutes/day vs +31.5 minutes/day, P = .03). Changes in time above range did not differ, whereas time below range (blood glucose <70 mg/dL; +23.5 minutes/day vs -8.9 minutes/day, P = .02) improved in the App group. BMI (-0.26 vs -0.59, P = .017) was reduced in the App group compared with the C group.Conclusion: Intervention with a smartphone app and intermittently scanned continuous glucose monitoring increased glycemic control accompanied by decreased carbohydrate intake and weight loss. Further trials are needed to confirm whether these interventions can reduce incident type 2 diabetes.
引用
收藏
页码:1060 / 1070
页数:11
相关论文
共 50 条
  • [41] The effect of a cluster-randomized controlled trial on lifestyle behaviors among families at risk for developing type 2 diabetes across Europe: the Feel4Diabetes-study
    Van Stappen, Vicky
    Cardon, Greet
    De Craemer, Marieke
    Mavrogianni, Christina
    Usheva, Nataliya
    Kivela, Jemina
    Wikstrom, Katja
    De Miquel-Etayo, Pilar
    Gonzalez-Gil, Esther M.
    Rado, Anett S.
    Nanasi, Anna
    Iotova, Violeta
    Manios, Yannis
    Brondeel, Ruben
    INTERNATIONAL JOURNAL OF BEHAVIORAL NUTRITION AND PHYSICAL ACTIVITY, 2021, 18 (01)
  • [42] A Smartphone App (TRIANGLE) to Change Cardiometabolic Risk Behaviors in Women Following Gestational Diabetes Mellitus: Intervention Mapping Approach
    Potzel, Anne Lotte
    Gar, Christina
    Seissler, Jochen
    Lechner, Andreas
    JMIR MHEALTH AND UHEALTH, 2021, 9 (05):
  • [43] An evaluation of the DEXLIFE ‘self-selected’ lifestyle intervention aimed at improving insulin sensitivity in people at risk of developing type 2 diabetes: study protocol for a randomised controlled trial
    Grainne M. O’Donoghue
    Aileen Kennedy
    Gregers Stig Andersen
    Eoin Durkan
    Tanja Thybo
    Margaret Sinnott
    John J. Nolan
    Donal J. O’Gorman
    Trials, 16
  • [44] An evaluation of the DEXLIFE 'self-selected' lifestyle intervention aimed at improving insulin sensitivity in people at risk of developing type 2 diabetes: study protocol for a randomised controlled trial
    O'Donoghue, Grainne M.
    Kennedy, Aileen
    Andersen, Gregers Stig
    Durkan, Eoin
    Thybo, Tanja
    Sinnott, Margaret
    Nolan, John J.
    O'Gorman, Donal J.
    TRIALS, 2015, 16
  • [45] Randomized controlled trial of prepregnancy lifestyle intervention to reduce recurrence of gestational diabetes mellitus
    Phelan, Suzanne
    Jelalian, Elissa
    Coustan, Donald
    Caughey, Aaron B.
    Castorino, Kristin
    Hagobian, Todd
    Munoz-Christian, Karen
    Schaffner, Andrew
    Shields, Laurence
    Heaney, Casey
    McHugh, Angelica
    Wing, Rena R.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2023, 229 (02) : 158.e1 - 158.e14
  • [46] PRomotion Of Physical activity through structured Education with differing Levels of ongoing Support for people at high risk of type 2 diabetes (PROPELS): study protocol for a randomized controlled trial
    Tom Yates
    Simon Griffin
    Danielle H Bodicoat
    Gwen Brierly
    Helen Dallosso
    Melanie J Davies
    Helen Eborall
    Charlotte Edwardson
    Mike Gillett
    Laura Gray
    Wendy Hardeman
    Sian Hill
    Katie Morton
    Stephen Sutton
    Jacqui Troughton
    Kamlesh Khunti
    Trials, 16
  • [47] PRomotion Of Physical activity through structured Education with differing Levels of ongoing Support for people at high risk of type 2 diabetes (PROPELS): study protocol for a randomized controlled trial
    Yates, Tom
    Griffin, Simon
    Bodicoat, Danielle H.
    Brierly, Gwen
    Dallosso, Helen
    Davies, Melanie J.
    Eborall, Helen
    Edwardson, Charlotte
    Gillett, Mike
    Gray, Laura
    Hardeman, Wendy
    Hill, Sian
    Morton, Katie
    Sutton, Stephen
    Troughton, Jacqui
    Khunti, Kamlesh
    TRIALS, 2015, 16
  • [48] Vitamin D Supplementation and Cognition in People with Type 2 Diabetes: A Randomized Control Trial
    Byrn, Mary A.
    Adams, William
    Penckofer, Sue
    Emanuele, Mary Ann
    JOURNAL OF DIABETES RESEARCH, 2019, 2019
  • [49] The effect of the smartphone app DiaCert on health related quality of life in patients with type 2 diabetes: results from a randomized controlled trial
    Madeleine Hummel
    Stephanie Erika Bonn
    Ylva Trolle Lagerros
    Diabetology & Metabolic Syndrome, 14
  • [50] Designing a lifestyle intervention to reduce risk of type 2 diabetes in postpartum mothers following gestational diabetes: An online survey with mothers and health professionals
    Moore, Amanda P.
    D'Amico, Maria I.
    Cooper, Natalie A. M.
    Thangaratinam, Shakila
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2018, 220 : 106 - 112